yubo_ex322.htm

EX-32.2 5 yubo_ex322.htm CERTIFICATION yubo_ex322.htm

EXHIBIT 32.2

CERTIFICATIONS OF CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the accompanying quarterly report on Form 10-Q of Yubo International Biotech Limited for the quarter ended June 30, 2023, the undersigned hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief, that:

(1)

such quarterly report on Form 10-Q for the quarter ended June 30, 2023 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

the information contained in such quarterly report on Form 10-Q for the quarter ended June 30, 2023 fairly presents, in all material respects, the financial condition and results of operations of Yubo International Biotech Limited.

Date: August 11, 2023

/s/ Lina Liu

Name: Lina Liu

Title: Chief Financial Officer

	(1)	such quarterly report on Form 10-Q for the quarter ended June 30, 2023 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

	(2)	the information contained in such quarterly report on Form 10-Q for the quarter ended June 30, 2023 fairly presents, in all material respects, the financial condition and results of operations of Yubo International Biotech Limited.

Date: August 11, 2023		/s/ Lina Liu
		Name: Lina Liu
		Title: Chief Financial Officer